PELP1 inhibition by SMIP34 reduces endometrial cancer progression via attenuation of ribosomal biogenesis.
Saved in:
| Title: | PELP1 inhibition by SMIP34 reduces endometrial cancer progression via attenuation of ribosomal biogenesis. |
|---|---|
| Authors: | Yang X; Department of Obstetrics and Gynecology, University of Texas Health San Antonio, TX, USA.; Department of Obstetrics and Gynecology, Second Xiangya Hospital, Central South University, Changsha, China., Liu Z; Department of Obstetrics and Gynecology, University of Texas Health San Antonio, TX, USA.; Department of Oncology, Xiangya Hospital, Central South University, Changsha, China., Tang W; Department of Obstetrics and Gynecology, University of Texas Health San Antonio, TX, USA.; Department of Obstetrics and Gynecology, Affiliated Hospital of Integrated Traditional Chinese and Western Medicine, Nanjing University of Chinese Medicine, China., Pratap UP; Department of Obstetrics and Gynecology, University of Texas Health San Antonio, TX, USA., Collier AB; Department of Obstetrics and Gynecology, University of Texas Health San Antonio, TX, USA., Altwegg KA; Department of Obstetrics and Gynecology, University of Texas Health San Antonio, TX, USA.; Mays Cancer Center, University of Texas Health San Antonio, TX, USA., Gopalam R; Department of Obstetrics and Gynecology, University of Texas Health San Antonio, TX, USA., Li X; Department of Obstetrics and Gynecology, University of Texas Health San Antonio, TX, USA., Yuan Y; Department of Biochemistry & Structural Biology, University of Texas Health San Antonio, TX, USA., Zhou D; Department of Biochemistry & Structural Biology, University of Texas Health San Antonio, TX, USA., Lai Z; Department of Molecular Medicine, Department of Population Sciences, and Greehey Children's Cancer Research Institute, University of Texas Health San Antonio, San Antonio, TX, USA., Chen Y; Department of Molecular Medicine, Department of Population Sciences, and Greehey Children's Cancer Research Institute, University of Texas Health San Antonio, San Antonio, TX, USA., Sareddy GR; Department of Obstetrics and Gynecology, University of Texas Health San Antonio, TX, USA.; Mays Cancer Center, University of Texas Health San Antonio, TX, USA., Valente PT; Department of Pathology, University of Texas Health San Antonio, TX, USA., Kost ER; Department of Obstetrics and Gynecology, University of Texas Health San Antonio, TX, USA., Viswanadhapalli S; Department of Obstetrics and Gynecology, University of Texas Health San Antonio, TX, USA.; Mays Cancer Center, University of Texas Health San Antonio, TX, USA., Vadlamudi RK; Department of Obstetrics and Gynecology, University of Texas Health San Antonio, TX, USA.; Mays Cancer Center, University of Texas Health San Antonio, TX, USA.; Audie L. Murphy Division, South Texas Veterans Health Care System, San Antonio, TX, USA. |
| Source: | Molecular oncology [Mol Oncol] 2024 Sep; Vol. 18 (9), pp. 2136-2156. Date of Electronic Publication: 2023 Nov 01. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: John Wiley & Sons, Inc Country of Publication: United States NLM ID: 101308230 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1878-0261 (Electronic) Linking ISSN: 15747891 NLM ISO Abbreviation: Mol Oncol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1878-0261 |
|---|---|
| DOI: | 10.1002/1878-0261.13539 |
